The adverse events of ibogaine in humans: an updated systematic review of the literature (2015–2020) (2022)
- Authors:
- USP affiliated authors: HALLAK, JAIME EDUARDO CECILIO - FMRP ; SANTOS, RAFAEL GUIMARÃES DOS - FMRP ; ROCHA, JULIANA MENDES - FMRP
- Unidade: FMRP
- DOI: 10.1007/s00213-021-05964-y
- Subjects: ALCALOIDES; ALUCINOGÊNICOS; USO DE MEDICAMENTOS; INTERAÇÃO ENTRE ALIMENTOS E MEDICAMENTOS
- Keywords: Ibogaine; Noribogaine; Adverse events; Safety; Drug interactions
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Heidelberg
- Date published: 2022
- Source:
- Título: Psychopharmacology
- ISSN: 0033-3158
- Volume/Número/Paginação/Ano: v. 239, n. 6, p. 1977-1987, 2022
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
ONA, Genís et al. The adverse events of ibogaine in humans: an updated systematic review of the literature (2015–2020). Psychopharmacology, v. 239, n. 6, p. 1977-1987, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00213-021-05964-y. Acesso em: 03 nov. 2024. -
APA
Ona, G., Rocha, J. M., Bouso, J. C., Hallak, J. E. C., Borràs, T., Colomina, M. T., & Santos, R. G. dos. (2022). The adverse events of ibogaine in humans: an updated systematic review of the literature (2015–2020). Psychopharmacology, 239( 6), 1977-1987. doi:10.1007/s00213-021-05964-y -
NLM
Ona G, Rocha JM, Bouso JC, Hallak JEC, Borràs T, Colomina MT, Santos RG dos. The adverse events of ibogaine in humans: an updated systematic review of the literature (2015–2020) [Internet]. Psychopharmacology. 2022 ; 239( 6): 1977-1987.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1007/s00213-021-05964-y -
Vancouver
Ona G, Rocha JM, Bouso JC, Hallak JEC, Borràs T, Colomina MT, Santos RG dos. The adverse events of ibogaine in humans: an updated systematic review of the literature (2015–2020) [Internet]. Psychopharmacology. 2022 ; 239( 6): 1977-1987.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1007/s00213-021-05964-y - Identifying setting factors associated with improved ibogaine safety: a systematic review of clinical studies
- Tripping to cope: coping strategies and use of hallucinogens during the COVID-19 pandemic in three cultural contexts
- The use of classic hallucinogens/psychedelics in a therapeutic context: healthcare policy opportunities and challenges
- Longitudinal and transcultural assessment of the relationship between hallucinogens, well-being, and post-traumatic growth during the COVID-19 pandemic
- Cross-sectional associations between lifetime use of psychedelic drugs and psychometric measures during the COVID-19 confinement: a transcultural study
- Therapeutic use of serotoninergic hallucinogens: a review of the evidence and of the biological and psychological mechanisms
- Polypharmacology or “pharmacological promiscuity” in psychedelic research: what are we missing?
- Effects of ayahuasca on mental health and quality of life in naïve users: a longitudinal and cross-sectional study combination
- Underground ibogaine use for the treatment of substance use disorders: aqualitative analysis of subjective experiences
- Hallucinations and hallucinogens: psychopathology or wisdom?
Informações sobre o DOI: 10.1007/s00213-021-05964-y (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | 003117369.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
